Other OTC • Healthcare • Drug Manufacturers - General • FR • USD
Sanofi (SNYNF) has a consensus analyst rating of Buy, based on 23 analysts covering the stock. Of those, 11 recommend buying, 9 recommend holding, and 3 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.